CONSOLIDATED URANIUM INC (CUR.CA) Fundamental Analysis & Valuation

TSX-V:CUR • CA21024C1014

Current stock price

1.93 CAD
+0.05 (+2.66%)
Last:

This CUR.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CUR.CA Profitability Analysis

1.1 Basic Checks

  • CUR had negative earnings in the past year.
  • CUR had a negative operating cash flow in the past year.
CUR.CA Yearly Net Income VS EBIT VS OCF VS FCFCUR.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

  • CUR's Return On Assets of -410.01% is on the low side compared to the rest of the industry. CUR is outperformed by 93.10% of its industry peers.
  • CUR's Return On Equity of -563.23% is on the low side compared to the rest of the industry. CUR is outperformed by 83.83% of its industry peers.
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROIC N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
CUR.CA Yearly ROA, ROE, ROICCUR.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300 -400

1.3 Margins

  • CUR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CUR.CA Yearly Profit, Operating, Gross MarginsCUR.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

3

2. CUR.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CUR has been increased compared to 1 year ago.
  • The debt/assets ratio for CUR has been reduced compared to a year ago.
CUR.CA Yearly Shares OutstandingCUR.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
CUR.CA Yearly Total Debt VS Total AssetsCUR.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

2.2 Solvency

  • CUR has an Altman-Z score of -2.57. This is a bad value and indicates that CUR is not financially healthy and even has some risk of bankruptcy.
  • CUR has a Altman-Z score of -2.57. This is in the lower half of the industry: CUR underperforms 69.08% of its industry peers.
  • CUR has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • CUR's Debt to Equity ratio of 0.03 is on the low side compared to the rest of the industry. CUR is outperformed by 63.02% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -2.57
ROIC/WACCN/A
WACCN/A
CUR.CA Yearly LT Debt VS Equity VS FCFCUR.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

  • CUR has a Current Ratio of 3.60. This indicates that CUR is financially healthy and has no problem in meeting its short term obligations.
  • CUR's Current ratio of 3.60 is in line compared to the rest of the industry. CUR outperforms 58.86% of its industry peers.
  • CUR has a Quick Ratio of 3.60. This indicates that CUR is financially healthy and has no problem in meeting its short term obligations.
  • CUR has a Quick ratio (3.60) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
CUR.CA Yearly Current Assets VS Current LiabilitesCUR.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M

0

3. CUR.CA Growth Analysis

3.1 Past

  • CUR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.86%, which is quite impressive.
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • CUR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.49% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CUR.CA Yearly EPS VS EstimatesCUR.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 -0.1 -0.2 -0.3 -0.4

0

4. CUR.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CUR.CA Price Earnings VS Forward Price EarningsCUR.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CUR.CA Per share dataCUR.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.49%
EPS Next 3YN/A

0

5. CUR.CA Dividend Analysis

5.1 Amount

  • CUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CUR.CA Fundamentals: All Metrics, Ratios and Statistics

CONSOLIDATED URANIUM INC

TSX-V:CUR (12/8/2023, 7:00:00 PM)

1.93

+0.05 (+2.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap199.71M
Revenue(TTM)N/A
Net Income(TTM)-79.64M
Analysts84
Price Target5.1 (164.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)25%
PT rev (3m)25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 14.12
P/tB 14.12
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -410.01%
ROE -563.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-106.62%
ROA(5y)-158.47%
ROE(3y)-131.22%
ROE(5y)-182.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.53%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -2.57
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.32%
EPS Next Y-147.2%
EPS Next 2Y-1.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.75%
OCF growth 3YN/A
OCF growth 5YN/A

CONSOLIDATED URANIUM INC / CUR.CA Fundamental Analysis FAQ

What is the fundamental rating for CUR stock?

ChartMill assigns a fundamental rating of 1 / 10 to CUR.CA.


Can you provide the valuation status for CONSOLIDATED URANIUM INC?

ChartMill assigns a valuation rating of 0 / 10 to CONSOLIDATED URANIUM INC (CUR.CA). This can be considered as Overvalued.


How profitable is CONSOLIDATED URANIUM INC (CUR.CA) stock?

CONSOLIDATED URANIUM INC (CUR.CA) has a profitability rating of 0 / 10.